Who we are

Hands with hepatitis wrist bands

Who we are

The Coalition for Global Hepatitis Elimination (CGHE)

To catalyze progress toward achievement of the goals for viral hepatitis elimination globally, the Task Force for Global Health (TFGH) launched the Coalition for Global Hepatitis Elimination (CGHE) in July 2019.

Modeled after other TFGH disease elimination programs, the CGHE provides services to assist the planning, implementation and evaluation of national and sub-national programs to eliminate hepatitis B virus (HBV) and hepatitis C virus (HCV) transmission and disease.

The Task Force for Global Health (TFGH)

The TFGH is an ideal home for CGHE. Started in 1984 by Dr. William Foege, a former CDC director and a leader of the successful global campaign to eradicate smallpox, the TFGH is the organization with the greatest experience globally in supporting disease elimination initiatives. From the start of the TFGH, Dr. Foege, joined by Drs. Walt Dowdle, Alan Hinman and other TFGH senior scientists led development of disease elimination and eradication as a field of public health. Their academic work established standard definitions for disease elimination and eradication, criteria for selecting feasible targets and essential components of successful programs. This academic work led to a global consensus that disease elimination and eradication are the ultimate goals of public health resulting in large benefits in lives saved and assuring health equity.

Why eliminate viral hepatitis?

Viral hepatitis is a large global health threat.  Hepatitis B virus (HBV) and hepatitis C virus (HCV) infection caused an estimated 1.3 million deaths in 2016 from cirrhosis and liver cancer. Approximately 325 million persons are living with HBV or HCV infection and an estimated 2.8 million new chronic infections occur annually.

Global hepatitis elimination goals

In 2016, the World Health Assembly (WHA) unanimously adopted the resolution that viral hepatitis should be eliminated by 2030. In the same year, the World Health Organization (WHO) published the Global Health Sector Strategy on viral hepatitis to reach this goal and defined elimination as a 90% reduction in incidence and 65% reduction in mortality for hepatitis B and C from 2015 to 2030. The International Task Force for Disease Eradication (ITFDE) adapted and endorsed the elimination goals of WHO, and HBV and HCV infections are recognised as feasible targets for elimination.

To guide implementation of the key interventions at a national level to achieve the global elimination goals, WHO set key service delivery targets for 2030:

Hepatitis B and C

  • 100% coverage of blood unit screening with quality assurance
  • 90% of injections administered with safety-engineered devices in and out of health facilities
  • 300 syringe and needle sets distributed per person who injects drugs

Hepatitis B

  • 90% coverage of 3-dose hepatitis B vaccine in infancy
  • 90% coverage of timely birth dose
  • 90% of persons affected aware of their status
  • 80% of persons diagnosed treated

Hepatitis C

  • 90% of persons affected aware of their status
  • 80% of persons diagnosed treated

Source: WHO Global health sector strategy on viral hepatitis. https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/